These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28346199)

  • 1. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):66-75. PubMed ID: 28346199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
    Wu G; Powers D; Yeung S; Chen F
    Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.
    Wu G; Powers D; Yeung S; Chen F; Neelon K
    Int J Pharm Compd; 2018; 22(1):86-94. PubMed ID: 29385389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Aprepitant Injectable Emulsion in Alternate Infusion Bags, in Refrigerated Storage, and Admixed with Dexamethasone and Palonosetron.
    Ottoboni T; Lerner L; Santhouse A
    Drug Des Devel Ther; 2021; 15():2519-2527. PubMed ID: 34163138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.
    Sun S; Schaller J; Placek J; Duersch B
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):509-13. PubMed ID: 23860958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection.
    Kintzel PE; Zhao T; Wen B; Sun D
    Am J Health Syst Pharm; 2014 Dec; 71(23):2061-5. PubMed ID: 25404598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical stability of palonosetron HCl in 4 infusion solutions.
    Trissel LA; Xu QA
    Ann Pharmacother; 2004 Oct; 38(10):1608-11. PubMed ID: 15328393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility and stability of aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
    Trissel LA; Zhang Y
    Int J Pharm Compd; 2004; 8(5):398-403. PubMed ID: 23924770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In brief: Severe hypersensitivity reactions with rolapitant IV emulsion (Varubi).
    Med Lett Drugs Ther; 2018 Jan; 60(1539):24. PubMed ID: 29431950
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
    Taormina D; Abdallah HY; Venkataramanan R; Logue L; Burckart GJ; Ptachcinski RJ; Todo S; Fung JJ; Starzl TE
    Am J Hosp Pharm; 1992 Jan; 49(1):119-22. PubMed ID: 1373936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of nitroglycerin in intravenous admixtures.
    Klamerus KJ; Ueda CT; Newton DW
    Am J Hosp Pharm; 1984 Feb; 41(2):303-5. PubMed ID: 6422753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags.
    Chen FC; Xiong H; Liu HM; Fang BX; Li P
    Am J Health Syst Pharm; 2015 Aug; 72(16):1374-8. PubMed ID: 26246294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures.
    Foley PT; Bosso JA; Bair JN; Townsend RJ
    Am J Hosp Pharm; 1985 Apr; 42(4):839-43. PubMed ID: 4014236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
    Zhang Y; Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):520-4. PubMed ID: 10932462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.
    Vermeire A; Remon JP
    Int J Pharm; 1999 Jan; 177(1):53-67. PubMed ID: 10205603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
    Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
    J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
    Stewart CF; Fleming RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1373-7. PubMed ID: 2368735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.